Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 30 July 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Post-transplant lymphoproliferative risk in pancreas recipients

Post-transplant lymphoproliferative in pancreas recipients has a worse prognosis than in other transplant recipients, and these immunosuppressed patients, who often face multiple transplants, may be at greater risk, reports the latest Transplantation.

News image

Post-transplant lymphoproliferative disorder is a rare, serious complication of transplantation.

The characteristics and associations of this disease in pancreas recipients have not been extensively studied.

Dr Steven Paraskevas and colleagues performed 787 pancreas and 569 kidney-pancreas transplants from 1988 to 2002 at their institution.

The research team reported that 18 pancreas recipients developed polymorphic posttransplant lymphoproliferative disorder or malignant lymphoma.

Data on clinical course, organ involvement, molecular characteristics was compiled from the institutional transplant database

Cytomegalovirus infection may play an antecedent role
Transplantation

The researchers also compiled data on and association with immunosuppression and recent cytomegalovirus infection.

Patient survival was compared to recipients of liver and kidney transplants at the same center by using Kaplan-Meier analysis.

The researchers found that the 5-year cumulative incidence of posttransplant lymphoproliferative in simultaneous pancreas-kidney recipients was 3%.

The 5-year cumulative incidence of post-transplant lymphoproliferative in pancreas after kidney recipients was 1.2%.

In pancreas transplant alone recipients, the 5-year cumulative incidence of the disease was 1%.

The team noticed a higher, but not significant, cumulative incidence in the more recent era since 1995.

Post-transplant lymphoproliferative in pancreas recipients carried a worse prognosis than in liver or kidney for recipients B-cell.

The researchers also observed that Post-transplant lymphoproliferative had a worse prognosis with early-onset, and Epstein Barr virus-positive lesions.

Posttransplant lymphoproliferative was more aggressive in pancreas recipients, with a higher stage at presentation and a trend to more bone marrow involvement.

The research team noted a tendency toward association with recent cytomegalovirus infection.

Since 1995, the team observed that post-transplant lymphoproliferative recipients have had a lower exposure to antilymphocyte preparations.

Dr Paraskevas' team concludes, “Posttransplant lymphoproliferative in pancreas recipients remains a rare but aggressive disease, and carries a worse prognosis in comparison to other transplant recipients.”

“These heavily immunosuppressed patients, who often face multiple transplants, may be at greater risk; cytomegalovirus infection may play an antecedent role.”

Transpl 2005: 80(5) 613-22
22 September 2005

Go to top of page Email this page Email this page to a colleague

 29 July 2016 
Susceptibility loci for gallstone disease
 29 July 2016 
H. pylori clarithromycin resistance in the USA
 29 July 2016 
Tool to diagnose Helicobacter-negative gastritis
 28 July 2016 
HCV eradication in cirrhotic patients
 28 July 2016 
Hep B screening and immunosuppressive therapy
 28 July 2016 
Pancreatitis after ERCP
 27 July 2016 
Gluten exposure in patients with celiac disease
 27 July 2016 
Bleeding GI recurrence with aspirin use
 27 July 2016 
IBD during pregnancy
 26 July 2016 
Gut microbiota and IBD
 26 July 2016 
Neighborhood variation in the use of laparoscopy for colon cancer
 26 July 2016 
Post-infectious IBS after C. diff
 25 July 2016 
Antibiotic prophylaxis for open colectomies
 25 July 2016 
Steroids in eosinophilic esophagitis
 25 July 2016 
Prevention of post-ERCP pancreatitis
 22 July 2016 
Upper GI lesions at primary diagnosis in IBD
 22 July 2016 
Duodenal villous atrophy and celiac disease
 22 July 2016 
Fecal calprotectin and IBD
 21 July 2016 
Radiofrequency ablation in Barrett's
 21 July 2016 
HCV eradication and inflammation in cirrhotic patients
 21 July 2016 
Surveillance of Barrett's
 20 July 2016 
Nonselective β-blockers and survival in cirrhosis
 20 July 2016 
Adolescent body mass index and and colorectal cancer risk
 20 July 2016 
Genetic biomarkers and IBD treatment response
 19 July 2016 
Prevention of chemotherapy-induced nausea and vomiting
 19 July 2016 
Screening diabetic patients for NAFLD
 19 July 2016 
Longterm clinical follow-up of living liver donors
 18 July 2016 
Rectal neuroendocrine tumors
 18 July 2016 
Liver cancer prediction scores in Hep B
 18 July 2016 
Liver stiffness measurement in chronic liver disease
 15 July 2016 
Patient reported outcomes in celiac disease
 15 July 2016 
Tonsillectomy and IBD risk
 15 July 2016 
Trainee IBD education in the USA
 14 July 2016 
Screening for familial pancreatic cancer
 14 July 2016 
Fecal calprotection for IBD prognosis
 14 July 2016 
Perianal surgery risk in Crohn's
 13 July 2016 
Psychological comorbidity and postinfectious IBS
 13 July 2016 
Lung transplant outcomes in Hep C
 13 July 2016 
Graft selection strategy in living donor liver transplants
 12 July 2016 
Surveillance endoscopy in Barrett's esophagus
 12 July 2016 
Therapy for iron deficiency anemia in IBD
 12 July 2016 
Treatment of pediatric acute liver failure
 11 July 2016 
Transition to adulthood in celiac disease
 11 July 2016 
Disturbed sleep and IBS
 11 July 2016 
Factors that influence access to liver transplant
 08 July 2016 
Mortality and peptic ulcers
 08 July 2016 
Genetic risk score and body mass index
 08 July 2016 
Statins and cirrhosis in Hep B
 07 July 2016 
Predicting food triggers in eosinophilic esophagitis
 07 July 2016 
Extraperitoneal vs transperitoneal colostomy for hernia
 07 July 2016 
Predictors fecal transplant failure in C. diff infection
 06 July 2016 
Therapies for Hep B cure
 06 July 2016 
Hospital volume and liver cancer survival
 06 July 2016 
Adverse events after outpatient colonoscopy
 05 July 2016 
Colorectal surgery and dialysis
 05 July 2016 
Exercise and gastroesophageal reflux
 05 July 2016 
Non-invasive scoring systems for fibrosis in NAFLD
 04 July 2016 
Autoimmunity in eosinophilic esophagitis and families
 04 July 2016 
Rectal cancer surgery checklist
 04 July 2016 
Guidelines on PPI and NSAID prescription

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us